We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$487M
AUM Growth
+$60.8M
Cap. Flow
+$38.3M
Cap. Flow %
7.87%
Top 10 Hldgs %
34.77%
Holding
122
New
17
Increased
29
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$7.16M
2
ABT icon
Abbott
ABT
+$4.51M
3
DUK icon
Duke Energy
DUK
+$3.52M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.16M
5
SCG
Scana
SCG
+$2.45M

Sector Composition

Rank Sector Weight
1 Healthcare 27.69%
2 Industrials 18.44%
3 Technology 17.48%
4 Utilities 8.95%
5 Energy 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
51
Amgen
AMGN
$203B
$3.17M 0.65%
20,813
-167
-0.8% -$26K
XRAY icon
52
Dentsply Sirona
XRAY
$2.59B
$3.15M 0.65%
50,823
-777
-2% -$47.8K
PLOW icon
53
Douglas Dynamics
PLOW
$1.07B
$3.14M 0.64%
121,971
-2,800
-2% -$62.9K
XBI icon
54
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$3.12M 0.64%
+57,720
New +$3.16M
EWS icon
55
iShares MSCI Singapore ETF
EWS
$1.01B
$3.06M 0.63%
141,005
+4,825
+4% +$103K
TRP icon
56
TC Energy
TRP
$73.5B
$2.82M 0.58%
62,450
-2,000
-3% -$82.5K
EEMV icon
57
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
$2.75M 0.56%
53,233
+366
+0.7% +$18.6K
MENT
58
DELISTED
Mentor Graphics Corp
MENT
$2.67M 0.55%
125,667
-1,600
-1% -$33.3K
SCG
59
DELISTED
Scana
SCG
$2.65M 0.54%
+35,025
New +$2.45M
XRX icon
60
Xerox
XRX
$337M
$2.54M 0.52%
101,756
+607
+0.6% +$16K
EWC icon
61
iShares MSCI Canada ETF
EWC
$6.04B
$2.36M 0.49%
96,400
-800
-0.8% -$19.6K
NEOG icon
62
Neogen
NEOG
$2.05B
$2.33M 0.48%
110,643
-933
-0.8% -$17.4K
ACM icon
63
Aecom
ACM
$9.07B
$2.32M 0.48%
73,000
-900
-1% -$28.5K
CBI
64
DELISTED
Chicago Bridge & Iron Nv
CBI
$2.16M 0.44%
+62,400
New +$2.3M
SBNY
65
DELISTED
Signature Bank
SBNY
$2.03M 0.42%
+16,250
New +$2.17M
ORBK
66
DELISTED
Orbotech Ltd
ORBK
$1.96M 0.4%
76,842
-400
-0.5% -$10.1K
XYL icon
67
Xylem
XYL
$28.5B
$1.93M 0.4%
43,300
-200
-0.5% -$8.69K
AAPL icon
68
Apple
AAPL
$4.89T
$1.82M 0.37%
76,108
-1,200
-2% -$29.8K
AGCO icon
69
AGCO
AGCO
$8.78B
$1.78M 0.37%
+37,800
New +$1.94M
CCC
70
DELISTED
Calgon Carbon Corp
CCC
$1.77M 0.36%
+134,500
New +$1.99M
ENTG icon
71
Entegris
ENTG
$19.7B
$1.73M 0.36%
119,594
-1,900
-2% -$26.1K
ACAS
72
DELISTED
American Capital Ltd
ACAS
$1.73M 0.35%
109,005
FLG
73
Flagstar Bank National Association
FLG
$5.77B
$1.71M 0.35%
+37,933
New +$1.73M
EWA icon
74
iShares MSCI Australia ETF
EWA
$1.34B
$1.66M 0.34%
85,300
-4,700
-5% -$91.7K
ZBH icon
75
Zimmer Biomet
ZBH
$17.7B
$1.57M 0.32%
13,400
-103
-0.8% -$11.7K

Similar funds

John G. Ullman & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, John G. Ullman & Associates held 122 positions worth $487M, up 14% from $426M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

John G. Ullman & Associates deployed $38.3M of net new capital in Q2 2016, opening 17 new positions and adding to 29 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.46M trimmed.

  • John G. Ullman & Associates's largest Q2 2016 buy was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.
  • John G. Ullman & Associates added most to TE Connectivity in Q2 2016, an estimated $7.16M increase.
  • John G. Ullman & Associates's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $1.46M.
  • John G. Ullman & Associates fully exited Booking.com in Q2 2016, selling an estimated $2.45M.
  • John G. Ullman & Associates's ten largest holdings make up 35% of its $487M portfolio in Q2 2016.
  • John G. Ullman & Associates opened 17 new positions and closed 5 in Q2 2016.
  • John G. Ullman & Associates's portfolio value rose 14% quarter-over-quarter to $487M.

Based on John G. Ullman & Associates's 13F filing for Q2 2016, filed 22 Jul 2016.